摘要
多项流行病学研究揭示了超重/肥胖与T2DM管理的严峻形势。T2DM患者多伴超重/肥胖,随着治疗的强化出现体重增加,对患者影响巨大。2016年ADA、2015年AACE及2013年CDS的指南均进一步强调了体重管理的重要性:建议对超重/肥胖的T2DM患者,通过生活方式、药物和手术等实现体重的有效控制;针对各种药物对体重的影响不同,应选择体重增加少的治疗策略,以预防因治疗带来的体重增加及不良结果;应用胰岛素治疗,需尽量避免或减少体重增加。
Recently, the incidence and prevalence of diabetes and obesity are rising rapidly all over the world. The type 2 diabetic patients are mostly over weighted or obese, with the intensification of diabetes treatment, the patients can have significant body weight gain, which has bad influence on the glycemic control and long term complications. The latest guidelines from ADA, AACE and CDS emphasis on the importance of body weight management： in overweight and obese patients with diabetes, lifestyle modification designed for weight loss, including medical and surgical interventions approved for the treatment of obesity, should be considered; When possible, medications should be chosen to promote weight loss or to be weight neutral.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2016年第9期861-864,共4页
Chinese Journal of Diabetes
关键词
糖尿病
体重增加
体重管理
地特胰岛素
Diabetes mellitus
Weight gain
Weight management
Insulin detemir
